S'abonner

COVID-19 Morbidity and Severity in Patients With Age-Related Macular Degeneration: A Korean Nationwide Cohort Study - 13/06/22

Doi : 10.1016/j.ajo.2021.05.024 
Jee Myung Yang a, b, c, Sung Yong Moon c, Joo Yong Lee a, Dritan Agalliu d, Dong Keon Yon c, e, 1, , Seung Won Lee c, f, 1,
a From Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine (J.M.Y, J.Y.L) 
b Department of Ophthalmology, Dongguk University Ilsan Hospital, Goyang, Republic of Korea 
c Department of Data Science, Sejong University College of Software Convergence, Seoul, Republic of Korea (S.Y.M, D.K.Y, S.W.L) 
d Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA (D.A) 
e Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, Republic of Korea (D.K.Y) 
f Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea (S.W.L) 

Inquiries to Dong Keon Yon, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, South Korea; and Seung Won Lee, Department of Data Science, Sejong University College of Software Convergence, 209 Neungdong-ro, Gwangjin-gu, Seoul, 05006, South Korea.Inquiries to Dong Keon Yon, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, South Korea; and Seung Won Lee, Department of Data Science, Sejong University College of Software Convergence, 209 Neungdong-ro, Gwangjin-gu, Seoul05006South Korea

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

HIGHLIGHTS

The first study showing an association between ophthalmologic comorbidities and risk of susceptibility to COVID-19 infection and severe COVID-19 outcomes.
A large nationwide cohort study with strong statistical evidence including patients aged ≥40 years who underwent SARS-CoV-2 testing in South Korea (total n = 135,435).
Well-designed statistical analysis using robust propensity-score matching increased the generalizability and reliability of the results.

Le texte complet de cet article est disponible en PDF.

Résumé

Purpose

To determine the potential association between age-related macular degeneration (AMD), a representative chronic age-related degenerative disease of the retina associated with inflammation and aging, and susceptibility to SARS-CoV-2 infection and severe COVID-19 outcomes.

Design

Nationwide cohort study with propensity-score matching.

Methods

A population-based nationwide cohort in Korea was examined. Data were obtained from the Health Insurance Review & Assessment Service of Korea, including all patients aged ≥40 years who underwent SARS-CoV-2 testing in South Korea between January 1, 2020 and May 15, 2020 (excluding self-referral). The primary outcome was SARS-CoV-2 test positivity and the secondary outcome was severe clinical outcome of COVID-19.

Results

The unmatched cohort consisted of 135,435 patients who were tested for SARS-CoV-2: 4531 patients (3.3%) tested positive for SARS-CoV-2 and 5493 (4.1%) had AMD. After propensity score matching, exudative AMD was associated with an increased likelihood of susceptibility to SARS-CoV-2 infection (adjusted odds ratio [aOR], 1.50; 95% confidence interval [CI], 1.03-2.25), and a considerably greater risk of severe clinical outcomes of COVID-19 (aOR, 2.26; 95% CI, 1.02-5.26), but not any AMD and non-exudative AMD.

Conclusions

In a Korean nationwide cohort, data suggest that clinicians should be aware of the greater risk of susceptibility to severe clinical outcomes of COVID-19 in patients with exudative AMD. These findings provide an improved understanding of the relationship between the pathogenesis of COVID-19 and chronic neurological disorders.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, age-related macular degeneration, exudative age-related macular degeneration, susceptibility, severity


Plan


 Supplemental Material available at AJO.com.


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 239

P. 159-169 - juillet 2022 Retour au numéro
Article précédent Article précédent
  • Gender Diversity on Corporate Boards Associated with Ophthalmology
  • Dominique Alexis, Corrinne Fahl, Eve Higginbotham, J. Bronwyn Bateman
| Article suivant Article suivant
  • Primary Mucoepidermoid Carcinoma of the Lacrimal Apparatus
  • Hui Sun, Rongrong Cai, Changwen Zhai, Wanjing Song, Ji Sun, Yingwen Bi

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.